Skip to main content

Day: December 27, 2024

Q-Gold Announces Closing of Oversubscribed Final Tranche of Flow-Through and Non-Flow Through Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES(All figures in Canadian dollars unless otherwise stated) TORONTO, Dec. 27, 2024 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd (TSXV: QGR, OTC: QGLDF, FRA: QX9G) (“Q-Gold” or the “Company”) is pleased to announce that it has closed a final tranche of previously announced non-brokered flow-through and non-flow through private placement (the “Offering”) for gross proceeds of C$357,999.88 (the “Final Tranche”). Under the Final Tranche, the Company issued (a) 1,925,000 flow-through units at $0.16 per unit (the “FT Units”), each FT Unit consisting of one flow-through common share (the “FT Shares”) and one-half of a warrant, each whole warrant exercisable at $0.20 per share for 24 months (the “FT Warrants”) and (b) 357,142 non-flow through units...

Continue reading

FOBI AI Inc. Announces Proposed Private Placement and BCSC Order

Vancouver, BC, Dec. 27, 2024 (GLOBE NEWSWIRE) — FOBI AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (“Fobi” or the “Company”) announces that it has applied to its principal regulator, the British Columbia Securities Commission (“BCSC”), for a partial revocation order (the “Partial Revocation Order”) of the ongoing failure-to-file cease trade order (“FFCTO”) ordered by the BCSC on November 1, 2024, in order to complete a non-brokered private placement offering (the “Proposed Offering”) of 56,114,400 units of the Company (the “Units”) to a single subscriber (the “Subscriber”) at a price per Unit of US$0.04 for aggregate gross proceeds of US$2,244,576 on a prospectus exempt basis. Each Unit is comprised of one common share in the capital of the Company (a “Unit Share”) and one common share purchase warrant (a “Unit Warrant”), each of which is...

Continue reading

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability, today announced that the Company’s Extraordinary General Meeting of Shareholders (the “Meeting), which was originally scheduled to be held on Monday, December 30, 2024, has been postponed. The Meeting is now scheduled to be held at 10:00 a.m. (Eastern Standard Time) on Monday, January 13, 2025 at the Company’s offices at 200 Donald Lynch Blvd., Marlborough, MA 01752, U.S.A. The record date for the Meeting, November 20, 2024, is unchanged and applies to the postponed Meeting. The Meeting has...

Continue reading

VR Resources Closes Non-Brokered Flow Through Private Placement

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. VANCOUVER, British Columbia, Dec. 27, 2024 (GLOBE NEWSWIRE) — VR Resources Ltd. (TSX.V: VRR; FSE: 5VR), (the “Company”), or (“VR”), announces it has closed the non-brokered flow-through private placement (the “FT Financing”) for gross proceeds of $400,000 through the issuance of 8,000,000 units (the “FT Units”) at a price of $0.05 per FT Unit. Each FT Unit consisting of one Flow Through common share (“FT Share”) of the Company and one-half of one non-flow through common share purchase warrant (each whole warrant a “Warrant”). Each Warrant entitles the holder to acquire one additional common share (“Share”) at an...

Continue reading

Genius Group Announces 177% Net Asset Growth in First Half of 2024

Genius Group increases Net Asset Value to $54.6 million, reduces net loss per share by 74% in First Half of 2024. Provides guidance of $75 million net asset value for Full Year with growth in Bitcoin Treasury. SINGAPORE, Dec. 27, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced its financial results for the first half of 2024. “Following a rationalization of our operations in the first half of the year, we are extremely pleased to report a stronger balance sheet and a reduction in operational expenses for the first six months of 2024. This trend has continued in the second half, with the launch of our Bitcoin-first strategy and growth of our Bitcoin Treasury.” said Roger Hamilton, CEO of Genius Group. Genius...

Continue reading

Brookfield Real Assets Income Fund Inc. Declares Q1 2025 Distribution Schedule

NEW YORK, Dec. 27, 2024 (GLOBE NEWSWIRE) — Brookfield Real Assets Income Fund Inc. (NYSE: RA) (the “Fund”) today announced that its Board of Directors (the “Board”) declared the Fund’s monthly distributions for January, February and March 2025. Distribution DeclarationMonth Record Date Ex-Dividend Date Payable Date Amount per ShareJanuary 2025 January 9, 2025 January 9, 2025 January 23, 2025 $0.1180February 2025 February 6, 2025 February 6, 2025 February 20, 2025 $0.1180March 2025 March 13, 2025 March 13, 2025 March 27, 2025 $0.1180Shares purchased on or after the applicable ex-distribution dates will not receive the distributions discussed above. Distributions may include net investment income, capital gains and/or return of capital. Any portion of the Fund’s distributions that is a return of capital does not necessarily...

Continue reading

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

Proposed merger would add a differentiated Phase 3 TROP2 Antibody-drug Conjugate (ADC) to the combined company’s pipeline PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications. Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted...

Continue reading

Nokia Corporation: Repurchase of own shares on 27.12.2024

Nokia CorporationStock Exchange Release27 December 2024 at 22:30 EET Nokia Corporation: Repurchase of own shares on 27.12.2024 Espoo, Finland – On 27 December 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 875,685 4.27CEUX – –BATE – –AQEU – –TQEX – –Total 875,685 4.27* Rounded to two decimals On 22 November 2024, Nokia announced that its Board of Directors is initiating a share buyback program to offset the dilutive effect of new Nokia shares issued to the shareholders of Infinera Corporation and certain Infinera Corporation share-based incentives. The repurchases in compliance with...

Continue reading

SAFE GROUP – Half-Year Financial Report as of June 30, 2024

HALF-YEAR FINANCIAL REPORT AS OF JUNE 30, 2024 December 27, 2024, 6.00 p.m. Safe Group announces that it has made available to the public and filed with the Autorité des Marchés Financiers its half-year financial report as of June 30, 2024. The 2024 Half-Year Financial Report can be found on www.safegrp.com website in the Investors – Documentations section. About Safe Group Safe Group is a French medical technology group that brings together Safe Orthopaedics, a pioneer in ready-to-use technologies for spine pathologies, and Safe Medical (formerly LCI Medical), a medical device subcontractor for orthopedic surgeries. The group employs approximately 100 people.Safe Orthopaedics develops and manufactures kits combining sterile implants and ready-to-use instruments, available at any time to the surgeon. These technologies are part of a minimally...

Continue reading

Equasens: strategic acquisition of Calimed, a SaaS software expert for private practitioners and surgeons

Villers-lès-Nancy, 27 December 2024 – 6:00 p.m. (CET)PRESS RELEASE Equasens strengthens its presence in the healthcare software market with the strategic acquisition of Calimed, a SaaS software expert for private practitioners and surgeons Equasens Group (Euronext Paris™ – Compartment B – FR 0012882389 -EQS), a leading provider of digital solutions for healthcare professionals, acquires a 90% majority stake in Calimed SAS, a pure player in the market for 100% cloud-based medical Practice Management Software (PMS) operating under the Calimed Santé brand. The acquisition of Calimed will contribute to Equasens Group’s strategy of strengthening its position in the French PMS market by increasing its market share and expanding its portfolio of online solutions to support the digital transition of medical practices....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.